Condition: Urinary Tract Infection Bacterial · Sponsor: Adaptive Phage Therapeutics, Inc.
This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Universal Axon Clinical Research | Doral, Florida, United States | — |
| AdMed Research | Miami, Florida, United States | — |
| AMPM Research Clinic | Miami Gardens, Florida, United States | — |
| Innovation Medical Research Center, Inc | Palmetto Bay, Florida, United States | — |
| Henry Ford Hospital | Detroit, Michigan, United States | — |
| James J. Peters VA Medical Center | The Bronx, New York, United States | — |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | — |
| DHR Health Institute for Research and Development | Edinburg, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04287478